Efficacy and Safety of Low-Dose Oral Minoxidil in Men with Androgenic Alopecia

    December 2020 in “ Dermatología argentina ”
    Federico Pastore
    Studysummary In this study, oral minoxidil at a dose of 1.25 mg/day for 24 weeks was examined as a sole treatment for androgenetic alopecia in 32 patients, including those who had not responded to prior topical minoxidil or oral finasteride therapies.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dermatolarg.org.ar →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Efficacy and Safety of Very-Low-Dose Oral Minoxidil 1.25 mg in Male Androgenetic Alopecia Journal of The American Academy of Dermatology · 2020

    Related research 5

    1. Allergic Contact Dermatitis Due to Minoxidil in a Patient With Alopecia Areata Actas Dermo-Sifiliográficas · 2022
    2. Pustular Dermatosis of the Scalp Due to Topical Minoxidil 5% 2018
    3. Effectivity of Minoxidil as a Treatment for Alopecia Areata DOAJ (DOAJ: Directory of Open Access Journals) · 2013
    4. Topical Minoxidil in the Treatment of Alopecia Areata Plastic & Reconstructive Surgery · 1985
    5. Alopecia Areata Treated With Topical Minoxidil Archives of Dermatology · 1984